Identification of Response Predictors to Capecitabine/Temozolomide in Metastatic Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Cives, Mauro [1 ]
Ghayouri, Masoumeh [1 ]
Brelsford, Marjorie [1 ]
Black, Michael [1 ]
Rizzo, Anthony [2 ]
Meeker, Alan [2 ]
Strosberg, Jonathan [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
PANCREAS | 2016年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：473 / 474
页数：2
相关论文
共 50 条
  • [21] A Retrospective Study of Capecitabine/Temozolomide (CAPTEM) Regimen in the Treatment of Metastatic Pancreatic Neuroendocrine Tumors (pNETs) after Failing Previous Therapy
    Saif, Muhammad Wasif
    Kaley, Kristin
    Brennan, Marianne
    Garcon, Marie Carmel
    Rodriguez, Gladys
    Rodriguez, Teresa
    JOURNAL OF THE PANCREAS, 2013, 14 (05): : 498 - 501
  • [22] Combination of Capecitabine and Temozolomide for Advanced Thymic Neuroendocrine Tumors
    Wang, X.
    Li, Y. L.
    Shi, Y. F.
    Chen, Y. Y.
    Qiu, X. D.
    Dou, D.
    Luo, J.
    Tan, H. Y.
    NEUROENDOCRINOLOGY, 2018, 106 : 207 - 207
  • [23] Effective treatment of neuroendocrine tumors With temozolomide and capecitabine.
    Fine, RL
    Fogelman, DR
    Schreibman, SM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 361S - 361S
  • [24] Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.
    Dogan, Izzet
    Tastekin, Didem
    Karabulut, Senem
    Sakar, Burak
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [25] Sequential Capecitabine/Temozolomide and Sunitinib Treatment in Patients With Metastatic Well-Differentiated Grade 1/Grade 2 Pancreatic Neuroendocrine Tumors
    Gao, Heli
    Dong, Jia
    Zhang, Wuhu
    Xu, Huaxiang
    Ye, Longyun
    Li, Hao
    Ni, Quanxing
    Wang, Wenquan
    Liu, Liang
    ENDOCRINE PRACTICE, 2022, 28 (03) : 292 - 297
  • [26] Distinctive grade based on Ki67 index and immune microenvironment of metastatic pancreatic neuroendocrine tumors responding to capecitabine plus temozolomide
    Gao, Heli
    Zhang, Wuhu
    Li, Zheng
    Liu, Wensheng
    Liu, Mengqi
    Zhuo, Qifeng
    Shi, Yihua
    Xu, Wenyan
    Zhou, Chenjie
    Qin, Yi
    Xu, Jin
    Chen, Jie
    Yu, Xianjun
    Xu, Xiaowu
    Ji, Shunrong
    BMC CANCER, 2024, 24 (01)
  • [27] Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
    Devata, Sumana
    Kim, Edward J.
    CASE REPORTS IN ONCOLOGY, 2012, 5 (03): : 622 - 626
  • [28] Efficacy of capecitabine and temozolomide in small bowel (midgut) neuroendocrine tumors
    Al-Toubah, T.
    Strosberg, J.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 130 - 130
  • [29] Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors
    Al-Toubah, Taymeyah
    Morse, Brian
    Strosberg, Jonathan
    CURRENT ONCOLOGY, 2022, 29 (02) : 510 - 515
  • [30] Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors
    Al-Toubah, Taymeyah
    Morse, Brian
    Strosberg, Jonathan
    PANCREAS, 2022, 51 (03) : E39 - E40
12345